Literature DB >> 12524559

Cervical myelopathy associated with degenerative spine disease and ossification of the posterior longitudinal ligament.

Meic H Schmidt1, Alfredo Quinones-Hinojosa, William S Rosenberg.   

Abstract

Cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament are two of the leading etiologies of spinal cord damage in older patients. For most patients, the natural history is one of slow stepwise decline in function. With nonsurgical therapy only 30 to 50% of patients are expected to stabilize. Surgical options include anterior and posterior surgical decompression, spinal canal expansion, and spinal column stabilization. Prospective, randomized trials with standardized outcome measures are needed to clarify the benefit of surgery conclusively.

Entities:  

Mesh:

Year:  2002        PMID: 12524559     DOI: 10.1055/s-2002-36537

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

1.  Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: a phase I and IIa clinical trial.

Authors:  Tsuyoshi Sakuma; Masashi Yamazaki; Akihiko Okawa; Hiroshi Takahashi; Kei Kato; Mitsuhiro Hashimoto; Koichi Hayashi; Takeo Furuya; Takayuki Fujiyoshi; Junko Kawabe; Chikato Mannoji; Ryo Kadota; Masayuki Hashimoto; Kazuhisa Takahashi; Masao Koda
Journal:  Eur Spine J       Date:  2011-09-21       Impact factor: 3.134

2.  Is ossification of posterior longitudinal ligament an enthesopathy?

Authors:  Jian Chen; Dianwen Song; Xinwei Wang; Xiaolong Shen; Yang Li; Wen Yuan
Journal:  Int Orthop       Date:  2010-11-23       Impact factor: 3.075

3.  Effectiveness of multiple-level decompression in laminoplasty and simultaneous C1 laminectomy for patients with cervical myelopathy.

Authors:  Junwei Zhang; Shigeru Hirabayashi; Kunio Saiki; Hiroya Sakai
Journal:  Eur Spine J       Date:  2005-12-21       Impact factor: 3.134

4.  Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.

Authors:  Hiroshi Takahashi; Yasuchika Aoki; Arata Nakajima; Masato Sonobe; Fumiaki Terajima; Masahiko Saito; Takuya Miyamoto; Keita Koyama; Keiichiro Yamamoto; Takeo Furuya; Masao Koda; Seiji Ohtori; Masashi Yamazaki; Koichi Nakagawa
Journal:  Eur Spine J       Date:  2018-03-19       Impact factor: 3.134

5.  Prevalence and progression of radiographic ossification of the posterior longitudinal ligament and associated factors in the Japanese population: a 3-year follow-up of the ROAD study.

Authors:  N Yoshimura; K Nagata; S Muraki; H Oka; M Yoshida; Y Enyo; R Kagotani; H Hashizume; H Yamada; Y Ishimoto; M Teraguchi; S Tanaka; H Kawaguchi; Y Toyama; K Nakamura; T Akune
Journal:  Osteoporos Int       Date:  2013-08-22       Impact factor: 4.507

6.  Association of a BMP9 haplotype with ossification of the posterior longitudinal ligament (OPLL) in a Chinese population.

Authors:  Yuan Ren; Zhi-zhong Liu; Jie Feng; Hong Wan; Jun-hua Li; Hao Wang; Xin Lin
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

7.  A higher frequency of lumbar ossification of the posterior longitudinal ligament in elderly in an outpatient clinic in Japan.

Authors:  Toshikatsu Okumura; Masumi Ohhira; Shima Kumei; Tsukasa Nozu
Journal:  Int J Gen Med       Date:  2013-08-27

8.  Adverse effect of trauma on neurologic recovery for patients with cervical ossification of the posterior longitudinal ligament.

Authors:  Soo Eon Lee; Tae-Ahn Jahng; Hyun-Jib Kim
Journal:  Global Spine J       Date:  2015-01-07

Review 9.  Ossification of the Posterior Longitudinal Ligament in Cervical Spine: Prevalence, Management, and Prognosis.

Authors:  Jau-Ching Wu; Yu-Chun Chen; Wen-Cheng Huang
Journal:  Neurospine       Date:  2018-03-28

10.  A new Enpp1 allele, Enpp1(ttw-Ham), identified in an ICR closed colony.

Authors:  Shuji Takabayashi; Shintaro Seto; Hideki Katoh
Journal:  Exp Anim       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.